Equinor ASA
8.6.2026 17:15:34 CEST | Globenewswire | Press release
Election of shareholder representatives to the board of directors of Equinor ASA
Election of shareholder representatives to the board of directors of Equinor ASA
The corporate assembly of Equinor ASA (OSE:EQNR, NYSE:EQNR) has on 8 June 2026 elected Jarle Roth as new chair of the board of directors of Equinor ASA.
The corporate assembly re-elected Anne Drinkwater as deputy chair and Finn Bjørn Ruyter, Haakon Bruun-Hanssen, Mikael Karlsson, Fernanda Lopes Larsen and Dawn Summers were re-elected as members of the board of directors of Equinor ASA. The current chair of the board, Jon Erik Reinhardsen, will resign from the board of directors.
The shareholder representatives of the board of directors of Equinor ASA are elected with effect from 1 July 2026 and until the ordinary election to the board of directors in June 2027.
Contacts:
- Nils Morten Huseby, chair of the nomination committee
- All enquiries to be directed through Equinor Corporate Press Office,
Sissel Rinde, +47 412 60 584
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
FireFly Metals Limited25.8.2026 02:49:03 CEST | Press release
Investor Presentation: Green Bay Preliminary Economic Assessment and Capital Raising
FireFly Metals Limited25.8.2026 02:44:28 CEST | Press release
Economic study demonstrates scale, grade, long life, growth potential and robust financial returns
Royal Philips24.8.2026 23:04:56 CEST | Press release
Philips prices EU green bond for EUR 650M
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom